GINA PALOMO: Open Payments
NPI 1144810862 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $826 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 9 | $524 |
| ABBVIE INC. | 9 | $305 |
| UCB, Inc. | 6 | $218 |
| Edwards Lifesciences Corporation | 1 | $200 |
| Neurelis, Inc. | 3 | $80 |
| SK Life Science, Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, QULIPTA, Fintepla, VALTOCO, UBRELVY, Briviact, WAINUA.
Industry payments across FL — which companies pay providers there.
